Unlock instant, AI-driven research and patent intelligence for your innovation.

Non-small cell lung cancer prognosis detection composition and applications thereof

A technology for non-small cell lung cancer and a composition, which is applied in recombinant DNA technology, biochemical equipment and methods, and microbial determination/testing, etc. Low specificity and low sensitivity, the effect of improving the detection rate

Active Publication Date: 2014-02-26
潘世扬
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, so far, there is still a lack of research data on the detection of miRNA changes in the blood of lung cancer patients before and after chemotherapy or radiotherapy, and there is no detailed report on the ideal miRNA and its combination for efficacy evaluation, so that miRNA can be detected Individualized treatment for lung cancer patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Non-small cell lung cancer prognosis detection composition and applications thereof
  • Non-small cell lung cancer prognosis detection composition and applications thereof
  • Non-small cell lung cancer prognosis detection composition and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Cell culture and in vitro experiments: SPC-A1 cell line (purchased from Shanghai Cell Bank of Chinese Academy of Sciences) was grown in RPMI1640 medium (purchased from Hyclone) containing 10% FBS, and log phase cells were seeded in 6-well plates, 2× 10 5 / Well, after the cells grow and adhere to the wall, wash with Hanks solution, add RPMI1640 culture medium containing 5μg / ml cisplatin (purchased from Shandong Qilu Pharmaceutical Factory) for 24h, 48h, 72h, 37℃, 5% CO 2 Cultivate under conditions. At the same time, a control group (without DDP) was set up, and each group was set up with 3 multiple holes. The supernatant corresponding to each time point of each group was collected and stored frozen at -70°C. The independent experiment was repeated 3 times.

[0046] Determination of cell apoptosis rate: Collect SPC-A1 cells at each time point in the above groups, wash twice with cold PBS, and adjust to a final concentration of 1×10 6 / mL of single cell suspension, take 1×10...

Embodiment 2

[0055] SPC-A1 cells were grown in RPMI1640 medium containing 10% fetal bovine serum, 100U / mL penicillin, and 100U / mL streptomycin at 37°C and 5% CO2 in a constant temperature incubator, and grew adherently. SPC-A1 cells were digested with 0.25% trypsin. Collect and count SPC-A1 cells to 1.5×10 6 The concentration of each / mL is added to a 6-well plate, 1mL per well, placed at 37℃, 5% CO 2 Cultivate in a constant temperature incubator. When the cells cover 75%~80% of the bottom of the plate, discard the culture medium, add the culture medium with the final concentration of DDP of 2.5μg / mL, 2mL / well, and set up a control group without DDP for 12h, 24h, 48h respectively And 72h.

[0056] Determination of cell apoptosis rate: the same as in Example 1.

[0057] RNA extraction and RT-PCR: respectively extract RNA from SPC-A1 culture supernatant sample and SPC-A1 intracellular RNA, and use 2720 gene amplification instrument to simultaneously reverse transcribe the target gene miR-27a (mi...

Embodiment 3

[0065] Participants: 26 patients with advanced lung cancer were from the First Affiliated Hospital of Nanjing Medical University from March 2010 to May 2012. There were 16 males and 10 females, aged 31-77 years (median age: 61 years). All patients were newly diagnosed with lung adenocarcinoma, unable to undergo radical surgery, and had not been treated with radiotherapy or chemotherapy. The diagnosis of lung cancer was confirmed by histopathological examination. The patient received first-line or second-line chemotherapy, docetaxel plus cisplatin as the first-line chemotherapy, and pemetrexed as the second-line chemotherapy. Seven of the patients completed 3 to 4 cycles of first-line chemotherapy, and the remaining 15 completed 1 to 2 cycles of short-term chemotherapy. After each chemotherapy cycle, an efficacy evaluation was performed according to RECIST standards, and the patients were followed up until March 2013.

[0066] The evaluation of chemotherapy efficacy is carried o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a non-small cell lung cancer prognosis detection composition and applications thereof. A non-small cell lung cancer prognostic marker, namely a miRNA combination, which can stably exist in human serum / plasma, is composed of miR-638 and miR-27a. The combination of primer and probe for detecting the non-small cell lung cancer prognostic marker miRNA combination is composed of a miR-638 primer and a fluorescent probe which are produced by the Applied Biosystems by Life Technologies, USA and have an article number of ABI assay ID 000200 and a miR-27a primer and a fluorescent probe which are produced by the Applied Biosystems by Life Technologies, USA and have an article number of ABI assay ID 001582. The selected specific serum / plasma miRNA is taken as a novel lung cancer marker, the method can be widely applied to the fields of prognostic judgment and curative effect supervision of non-small cell lung cancer, and the accuracy of the prognostic judgment on non-small cell lung cancer of the specific serum / plasma miRNA is far higher than that of the reported serum miRNA.

Description

Technical field [0001] The invention belongs to the field of biological detection, and relates to a non-small cell lung cancer prognosis detection composition and application thereof. Background technique [0002] Lung cancer is the most common malignant tumor in the world and the first cause of cancer-related deaths. About 1.61 million lung cancer cases are diagnosed each year, accounting for 12.7% of malignant tumors, and about 1.38 million lung cancer-related deaths, accounting for 18.2% of cancer-related deaths. Lung cancer is also one of the most common malignant tumors in my country. Its morbidity and mortality are the first in most areas of China, especially in large cities and areas with heavy industrial pollution. With the continuous growth of China's population and the intensification of population aging, coupled with changes in lifestyle, social, economic and environmental factors, the incidence and mortality of lung cancer have shown a significant upward trend. [000...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/113C12N15/11C12Q1/68
Inventor 潘世扬王芳徐建杨瑞霞黄珮珺徐婷张丽霞陈丹张燕谢而付顾兵蒋叶
Owner 潘世扬